European Biotech: The Flowering of an Industry or Tulip II?
This article was originally published in Start Up
Executive Summary
The central message at the Atlas Venture/Ernst & Young European Life Science Conference: the European start-up scene is red hot--hotter than it is in the US. One key reason for a flood of start-ups is the flood of venture funding which has followed the extraordinary performance (until recently) of UK biotech stocks. Another impetus has been Jurgen Ruttgers, Germany's minister of education and research, who has encouraged start-ups through various government spending programs.